Cover Image

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

Non-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of analgesic, anti-inflammatory and antipyretic effects make the drugs of this group very popular in patients with various diseases. The realization of NSAIDs in phar...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. Yu. Velts (Author), T. M. Bukatina (Author), E. O. Zhuravleva (Author), G. V. Kutekhova (Author), M. A. Darmostukova (Author), Yu. V. Olefir (Author), B. K. Romanov (Author), S. V. Glagolev (Author), V. A. Polivanov (Author)
Format:	Book
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nonsteroidal anti-inflammatory drugs: problems of safe use
by: N. Yu. Velts, et al.
Published: (2018)

Malaria and safety issues associated with antimalarial drugs
by: A. S. Kazakov, et al.
Published: (2018)

Standard form of a periodic safety update report
by: B. R. Romanov, et al.
Published: (2018)

Safety of Antibacterial and Antiprotozoal Medicinal Products
by: E. V. Shubnikova, et al.
Published: (2022)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018)

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018)

Perfection of management principles by the safety signals of medicinal products
by: B. K. Romanov, et al.
Published: (2018)

Safety of apremilast: risk of psychical disorders
by: T. M. Bukatina, et al.
Published: (2018)

On improving the safety of new direct acting oral anticoagulants
by: N. Yu. Velts, et al.
Published: (2018)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019)

Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy
by: E. O. Zhuravleva, et al.
Published: (2018)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019)

Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
by: E. O. Zhuravleva, et al.
Published: (2018)

Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2020)

Preparation of a periodic safety update report
by: B. K. Romanov, et al.
Published: (2018)

APPLICATION OF DRUG-RELATED PROBLEMS APPROACH TO ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS' SAFETY
by: A. V. Matveev, et al.
Published: (2019)

Nanoscale Therapeutic System: Safety Assessment Features
by: E. M. Bovina, et al.
Published: (2019)

Guidelines for the planning and implementation of pharmacovigilance systems audit
by: S. V. Glagolev, et al.
Published: (2018)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019)

Drug Safety Monitoring-International Information
by: E. V. Shubnikova, et al.
Published: (2020)

Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019)

Peculiarities of non-steroidal anti-inflammatory drugs in the treatment of complicated caries in patients with concomitant somatic pathology
by: L. Yu. Orekhova, et al.
Published: (2021)

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
by: E. V. Shubnikova, et al.
Published: (2020)

Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease
by: N. Yu. Velts, et al.
Published: (2022)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018)

Toxic reactions of non-steroidal anti-inflammatory drugs in the Russian Federation, analysis of the national database "Pharmacovigilance"
by: G. I. Syraeva, et al.
Published: (2023)

Drug Safety Monitoring Information
by: Elena V. Shubnikova, et al.
Published: (2020)

Information on the decisions of foreign regulatory authorities
by: T. M. Bukatina, et al.
Published: (2018)

Signal Messages in Pediatric Practice
by: G. V. Kutekhova, et al.
Published: (2018)

Typical pharmacovigilance system master file (PSMF)
by: B. K. Romanov, et al.
Published: (2018)

Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024)

Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
by: A. V. Philippova, et al.
Published: (2019)

Retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label
by: E. O. Zhuravleva, et al.
Published: (2022)

Foreign regulatory recommendations
by: T. M. Bukatina, et al.
Published: (2018)

The risk of an acute attack of angle-closure glaucoma during the treatment with modern antidepressant drugs
by: T. V. Romanova, et al.
Published: (2018)

The results of the analysis of materials on the safety of clinical trials
by: Yu. V. Olefir
Published: (2018)